Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

尼妥珠单抗通过抑制EGFR信号通路和细胞DNA修复，消除KYSE-150R食管癌细胞获得的放射抗性。